Loading...
Back to narrative

Update shared on05 Sep 2025

AnalystConsensusTarget's Fair Value
€52.55
22.8% undervalued intrinsic discount
05 Sep
€40.59
Loading
1Y
6.6%
7D
-0.6%

Following Accor’s H1 results, analysts tempered earnings and price targets amid reduced visibility and headwinds in associate income and FX, while maintaining a broadly positive long-term outlook, leaving the consensus analyst price target unchanged at €52.55.


Analyst Commentary


  • Reduced visibility following Accor’s first half results has led to more cautious outlooks from bearish analysts.
  • Bullish analysts expect continued RevPAR outperformance in Q2.
  • Lowered 2025 net income estimates due to weaker associate income and foreign exchange headwinds.
  • Incrementally lower price targets across the board reflect tempered earnings expectations, despite overall positive long-term views.
  • Persistent Buy or Overweight ratings from most bullish analysts signal confidence in Accor's fundamental resilience.

What's in the News


  • Accor is exploring a U.S. IPO for its lifestyle hotel venture Ennismore, which operates over 180 hotels under brands such as The Hoxton, Mondrian, 25hours Hotels, Hyde, and Morgans Originals (Bloomberg, company disclosures).
  • The potential IPO could value Ennismore at several billion dollars, though the discussions are at an early stage and may not result in a transaction (Bloomberg, company disclosures).
  • Accor has been engaging with advisers regarding the possible Ennismore listing but has not made any final decisions, and a company representative declined to comment on the matter (Bloomberg, company disclosures).
  • Megaworld Corporation announced a partnership with Accor to elevate the operating standards of select Megaworld Hotels & Resorts properties (company announcement).
  • As part of the new partnership, Belmont Hotel Mactan will transition to become Mercure Mactan Cebu, the first Accor-affiliated franchise in The Mactan Newtown township in Cebu, in 2025 (company announcement).

Valuation Changes


Summary of Valuation Changes for Accor

  • The Consensus Analyst Price Target remained effectively unchanged, at €52.55.
  • The Discount Rate for Accor remained effectively unchanged, at 9.09%.
  • The Future P/E for Accor remained effectively unchanged, at 21.12x.

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.